STRS Ohio’s SELLAS Life Sciences SLS Stock Holding History

STRS Ohio’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$385K	Buy	+26,100	New	+$180K	﹤0.01%	1274
2017 Q2	–	Hold	0	–	–	–	2006
2017 Q1	–	Hold	0	–	–	–	1924
2016 Q4	–	Hold	0	–	–	–	1986

Other funds holding SLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

STRS Ohio's SLS Position: Q2 2026 in Review

STRS Ohio opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 26,100 shares worth $385K. The stake represents ﹤0.01% of the portfolio and ranks #1274 among its holdings.

194 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

STRS Ohio held 26,100 shares of SELLAS Life Sciences worth $385K as of Q2 2026.
SELLAS Life Sciences was a new STRS Ohio position in Q2 2026.
SELLAS Life Sciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1274 holding.
194 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.